参考文献/References:
[1] Chang Y,Woo HG,Park J,et al. Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure:a nationwide population-based cohort study [J].Eur J Prev Cardiol,2020,27(17):1835-1845.
[2] Harada M,Melka J,Sobue Y,et al. Metabolic considerations in atrial fibrillation—mechanistic insights and therapeutic opportunities[J]. Circ J,2017,81(12):1749-1757.
[3] Lai S,Hua X,Gao R,et al. Combinational biomarkers for atrial fibrillation derived from atrial appendage and plasma metabolomics analysis[J].Sci Rep,2018,8(1):16930.
[4] Harskamp RE,Granger TM,Clare RM,et al. Peripheral blood metabolite profiles associated with new onset atrial fibrillation[J]. Am Heart J,2019,211:54-59.
[5] Opacic D,van Bragt KA,Nasrallah HM,et al. Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation[J]. Cardiovasc Res,2016,109(4):527-541.
[6] Harada M,Tadevosyan A,Qi X,et al. Atrial fibrillation activates AMP-dependent protein kinase and its regulation of cellular calcium handling:potential role in metabolic adaptation and prevention of progression[J]. J Am Coll Cardiol,2015,66(1):47-58.
[7] Qiu J,Zhou S,Liu Q,Energy metabolic alterations in the progression of atrial fibrillation:potential role of AMP-activated protein kinase as a critical regulator[J].Int J Cardiol,2016,212:14-15.
[8] Ozcan C,Dixit G,Li Z. Activation of AMP-activated protein kinases prevents atrial fibrillation[J]. J Cardiovasc Transl Res,2021,14(3):492-502.
[9] Hu HJ,Zhang C,Tang ZH,et al. Regulating the Warburg effect on metabolic stress and myocardial fibrosis remodeling and atrial intracardiac waveform activity induced by atrial fibrillation[J].Biochem Biophys Res Commun,2019,516(3):653-660.
[10] Liu Y,Bai F,Liu N,et al. The Warburg effect:a new insight into atrial fibrillation [J].Clin Chim Acta,2019,499:4-12.
[11] Yuan Y, Zhao J, Yan S, et al. Autophagy:a potential novel mechanistic contributor to atrial fibrillation[J].Int J Cardiol,2014,172 (2): 492 -494.
[12] Liu Y,Bai F,Liu N,et al. Metformin improves lipid metabolism and reverses the Warburg effect in a canine model of chronic atrial fibrillation[J].BMC Cardiovasc Disord,2020,20(1):50.
[13] She J,Guo M,Li H,et al. Targeting amino acids metabolic profile to identify novel metabolic characteristics in atrial fibrillation[J].Clin Sci (Lond),2018,132(19):2135-2146.
[14] Mayr M,Yusuf S,Weir G,et al. Combined metabolomic and proteomic analysis of human atrial fibrillation[J]. J Am Coll Cardiol,2008,51(5):585-594.
[15] Rusnak J,Behnes M,Saleh A,et al. Interventional left atrial appendage closure may affect metabolism of essential amino acids and bioenergetic efficacy[J]. Int J Cardiol,2018,268:125-131.
[16] Ko D,Riles EM,Marcos EG,et al. Metabolomic profiling in relation to new-onset atrial fibrillation (from the Framingham Heart Study)[J]. Am J Cardiol,2016,118(10):1493-1496.
[17] Jung Y,Cho Y,Kim N,et al. Lipidomic profiling reveals free fatty acid alterations in plasma from patients with atrial fibrillation[J].PLoS One,2018,13(5):e0196709.
[18] Reiner MF,Baumgartner P,Wiencierz A,et al. The omega-3 fatty acid eicosapentaenoic acid (EPA) correlates inversely with ischemic brain infarcts in patients with atrial fibrillation[J].Nutrients,2021,13(2):651.
[19] Shingu Y,Takada S,Yokota T,et al. Correlation between increased atrial expression of genes related to fatty acid metabolism and autophagy in patients with chronic atrial fibrillation[J].PLoS One,2020,15(4):e0224713.
[20] Darghosian L,Free M,Li J,et al. Effect of omega-three polyunsaturated fatty acids on inflammation,oxidative stress,and recurrence of atrial fibrillation[J].Am J Cardiol,2015,115(2):196-201.
[21] Colussi G,Catena C,Fagotto V,et al. Atrial fibrillation and its complications in arterial hypertension:The potential preventive role of ω-3 polyunsaturated fatty acids[J].Crit Rev Food Sci Nutr,2019,59(12):1937-1948.
[22] Yuan S,Larsson SC.Plasma phospholipid fatty acids and risk of atrial fibrillation:a mendelian randomization study[J].Nutrients,2019,11(7):1651.
[23] Lind L,Salihovic S,Sundstr?m J,et al. Multicohort metabolomics analysis discloses 9-decenoylcarnitine to be associated with incident atrial fibrillation[J].J Am Heart Assoc,2021,10(2):e017579.
[24]Smith E,Fernandez C,Melander O,et al. Altered acylcarnitine metabolism is associated with an increased risk of atrial fibrillation[J].J Am Heart Assoc,2020,9(21):e016737.
[25] Albert CM,Cook NR,Pester J ,et al. Effect of marine omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation:a randomized clinical trial[J].JAMA,2021,325(11):1061-1073.
[26] Korantzopoulos P,Letsas K,Fragakis N,et al. Oxidative stress and atrial fibrillation:an update[J].Free Radic Res,2018,52(11-12):1199-1209.
[27] Opacic D,van Bragt KA,Nasrallah HM,et al. Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation[J].Cardiovasc Res,2016,109(4):527-541.
[28] Wu X,Liu Y,Tu D,et al. Role of NLRP3-inflammasome/caspase-1/galectin-3 pathway on atrial remodeling in diabetic rabbits[J].J Cardiovasc Transl Res,2020,13(5):731-740.
[29] Scott L Jr ,Li N,Dobrev D.Role of inflammatory signaling in atrial fibrillation[J].Int J Cardiol,2019,287:195-200.
[30] Jie QQ,Li G,Duan JB,et al. Remodeling of myocardial energy and metabolic homeostasis in a sheep model of persistent atrial fibrillation[J].Biochem Biophys Res Commun,2019,517(1):8-14.
[31] Bersch-Ferreira ?C,Sampaio GR,Gehringer MO,et al. Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease,a cross-sectional study[J].Nutr J,2018,17(1):26.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(12):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(12):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(12):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(12):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(12):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]